Methylone for the Treatment for PTSD: Initial Results From an Open-Label Study (IMPACT-1)

被引：0
|
作者：
Jones, Amanda [1 ]
Warner-Schmidt, Jennifer [1 ]
Stogniew, Martin [1 ]
Mandell, Blake [1 ]
Kwak, Hannah [1 ]
Miller, Paul W. [1 ]
Ching, Terence H. W. [1 ]
Averill, Lynnette [1 ]
Kelmendi, Benjamin [1 ]
机构：
[1] Transcend Therapeut, New York, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷
关键词：
Methylone; PTSD; Transcend Therapeutics; Human; Clinical Trial;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P26
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [41] A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes
    Marwaha, Ashish K.
    Chow, Samuel
    Pesenacker, Anne M.
    Cook, Laura
    Sun, Annika
    Long, S. Alice
    Yang, Jennie H. M.
    Ward-Hartstonge, Kirsten A.
    Williams, Evangelia
    Domingo-Vila, Clara
    Halani, Khalif
    Harris, Kristina M.
    Tree, Timothy I. M.
    Levings, Megan K.
    Elliott, Thomas
    Tan, Rusung
    Dutz, Jan P.
    IMMUNOTHERAPY ADVANCES, 2022, 2 (01):
  • [42] Safety, Tolerability, and Efficacy of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder: Results from Two Open-Label Extension Trials
    Atkinson, Sarah
    Thurman, Louise
    Ramaker, Sara
    Buckley, Gina
    Jones, Sara Ramaker
    England, Richard
    Wajsbro, Dalia
    CNS SPECTRUMS, 2019, 24 (05) : 496 - 506
  • [43] A Comparison of Reboxetine and Amitryptilline in the Treatment of Fibromyalgia Syndrome with Co-morbid Depressive Symptoms: An Open-label Preliminary Study
    Konuk, Numan
    Ortancil, Ozgur
    Bostanci, Bora
    Kiran, Sibel
    Sapmaz, Perihan
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 20 (01): : 29 - 37
  • [44] Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): a prospective, open-label, phase II pilot study
    Kuhn, A.
    Landmann, A.
    Patsinakidis, N.
    Ruland, V.
    Nozinic, S.
    Ortiz, A. M. Perusquia
    Sauerland, C.
    Luger, T.
    Tsianakas, A.
    Bonsmann, G.
    LUPUS, 2016, 25 (12) : 1357 - 1364
  • [45] NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial
    Gerain, Jean
    Uebelhoer, Melanie
    Costes, Berenice
    Herman, Julie
    Pietri, Sandra
    Donneau, Anne-Francoise
    Monseur, Justine
    Henrotin, Yves
    FRONTIERS IN NUTRITION, 2023, 10
  • [46] Clinical effectiveness and safety experience with efalizumab in the treatment of patients with moderate-to-severe plaque psoriasis in Taiwan: results of an open-label, single-arm pilot study
    Tsai, T. F.
    Liu, M. T.
    Liao, Y. H.
    Licu, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (03) : 345 - 352
  • [47] Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial
    Robert Orenstein
    Erik R. Dubberke
    Sahil Khanna
    Christine H. Lee
    David Yoho
    Stuart Johnson
    Gail Hecht
    Herbert L. DuPont
    Dale N. Gerding
    Ken F. Blount
    Sarah Mische
    Adam Harvey
    BMC Infectious Diseases, 22
  • [48] Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial
    Orenstein, Robert
    Dubberke, Erik R.
    Khanna, Sahil
    Lee, Christine H.
    Yoho, David
    Johnson, Stuart
    Hecht, Gail
    DuPont, Herbert L.
    Gerding, Dale N.
    Blount, Ken F.
    Mische, Sarah
    Harvey, Adam
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [49] Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study
    Sakurai, Yuuichi
    Shiino, Madoka
    Okamoto, Hiroyuki
    Nishimura, Akira
    Nakamura, Koki
    Hasegawa, Setsuo
    ADVANCES IN THERAPY, 2016, 33 (09) : 1519 - 1535
  • [50] A Phase 1, Open-Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6-12 Years With Alopecia Areata
    Gonzalez, Mercedes E.
    Browning, John
    Smith, Stacy
    Plotka, Anna
    Zhu, Jing Daisy
    Parvatini, Shyam
    Huh, Yeamin
    Wolk, Robert
    PEDIATRIC DERMATOLOGY, 2025,
12345